Skip to page contentSkip to Rheumatology main navigationSkip to Services linksSkip to Research linksSkip to organizational linksSkip to Research additional information
Home    Patients/Community    Health Professionals    Businesses    Media    Volunteers    Job Seekers      
Park Nicollet Home Page
Home
About Us
Appointments
What Is Rheumatology?
Services
Begin Services links
End Services links
Diseases, Disorders
Medications
FAQ
Resources
Locations
Contact Us
Find a doctor or other provider
(by name, clinic or specialty)

Health Care Services
Health Advisor
Who We Are
Popular Health Interests
Health Care Products

Rheumatology Rheumatology
Rheumatology > Services > Research

Research

Rheumatology research focuses on clinical studies to evaluate innovative treatments for arthritis and other rheumatic diseases, quality of life and outcomes research. 

Rheumatology Research Center’s trained team of board-certified rheumatologists and dedicated clinical research staff conduct original and collaborative research for new medicines and therapies. We participate in multicenter trials to investigate new treatments and medications, and initiate our own studies to determine the best way to deliver those treatments and medications.

Why participate in a research study?

Taking part in a clinical study can result in benefits for yourself and others.

  • You may have access to the latest Food and Drug Administration approved drugs that are not yet on the market.
  • Associated medical care is sometimes covered by the study.
  • You may contribute to the understanding of disease or its treatment, and improve the lives of future generations.

Current studies

  • RACAT study
    The purpose of the RACAT Study is to compare two of the most effective medication combinations for treating rheumatoid arthritis. You may be eligible if you:
    • are age 18 or older
    • have been diagnosed with rheumatoid arthritis and have active disease
    • currently are receiving methotrexate at a dosage of 15 mg to 25 mg per week
  • ACT-STAR study
    The purpose of the ACT-STAR study is to investigate an experimental drug for treating rheumatoid arthritis.
    You may be eligible if you:
    • are age 18 or older
    • have been diagnosed with moderate to severe rheumatoid arthritis for at least six months and currently are having symptoms
    • have or have had inadequate response or safety or tolerability issues on your rheumatoid arthritis medication
  • NARAC study (a genetic study for rheumatoid arthritis)
    You may be eligible if:
    • you are age 18 or older
    • you have a rheumatoid arthritis diagnosis
    • both of your biological parents are willing to participate and donate blood samples

We also provide information on federally funded research at the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS). Find out about the breadth of research sponsored through NIAMS.

For more information, talk to your rheumatologist or call Park Nicollet Rheumatology Research Center at 952-993-2758.

Park Nicollet Clinic Rheumatology’s clinical research is under the auspices of the Park Nicollet Institute. Private donations to support clinical research at Park Nicollet are welcome.

,
Copyright Questions/Comments Privacy Site Usage Site Accessibility